GSK, Pfizer Agree To End Patent Fight Over RSV Vaccines

By Rae Ann Varona ( April 3, 2025, 11:37 PM EDT) — British pharmaceutical company GlaxoSmithKline PLC and New York-based Pfizer Inc. on Thursday agreed to end their legal fight over Pfizer’s respiratory syncytial virus vaccine Abrysvo that allegedly infringed GSK patents that Pfizer had countered were invalid or unenforceable….

SEO Powered Content & PR Distribution. Get Amplified Today.
PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
Source: https://www.law360.com/ip/articles/2321021?utm_source=rss&utm_medium=rss&utm_campaign=section

Generative Data Intelligence

GSK, Pfizer Agree To End Patent Fight Over RSV Vaccines